Skip to main content
SpringerLink
Log in

Amrubicin

Interstitial lung disease: 2 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Ishikawa H, et al. Clinical study of amrubicin-induced interstitial lung disease in lung cancer patients with interstitial lung abnormality. Respirology 26 (Suppl. 3): 322-323 abstr. P8-87, Nov 2021. Available from: URL: http://doi.org/10.1111/resp.14150_599 [abstract]

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Amrubicin. Reactions Weekly 1887, 51 (2022). https://doi.org/10.1007/s40278-022-07716-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-022-07716-7

Search

Navigation